Pham Quang X

Chairman, CEO and Interim CFO, Director, 10% OwnerCadrenal Therapeutics, Inc. (CVKD) · full profile →Form 4 · filed Jun 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$93K
Net Open-Market Flow
-$93K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 10, 2026Sell(S)4K$4.21$15K151K
Jun 9, 2026Sell(S)13K$4.06$53K154K
Jun 8, 2026Sell(S)6K$4.38$26K167K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-067484) within minutes of acceptance. Every field above traces to the original document. Verify it directly: